Sign in
SXTP Stock Price, Chart, Stats & News
60 Degrees Pharmaceuticals, Inc.
Save
60 Degrees Pharmaceuticals, Inc. (SXTP) does not currently pay a dividend.
1.44M
Market cap
–
Current P/E
–
Forward P/E
SXTP chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 19.14% |
Operating margin | -821.68% |
Pretax margin | -827.88% |
Net margin | -827.80% |
Effective tax rate | -0.02% |
ROA | -119.24% |
ROE | -212.63% |
D/E | 0.03x |
Interest coverage ratio | -1289.21x |
SXTP valuation
P/E | – |
P/S | 1.26x |
P/B | 0.31x |
P/CF | -0.20x |
P/FCF | -0.18x |
P/OCF | -0.20x |
PEG | -0.06x |
EV multiple | -0.66x |
About
60 Degrees Pharmaceuticals, Inc. is a specialty pharmaceutical firm dedicated to developing and bringing to market therapies aimed at preventing and treating infectious diseases within the United States. The company currently offers Arakoda, an approved medication for malaria prophylaxis. Its pipeline includes several investigational drugs: Tafenoquine, in its 'Arakoda regimen' formulation, is undergoing Phase IIb clinical trials for potential use against COVID-19.
Similar securities
Based on sector and market capitalization
Report issue